Immucell (ICCC) Market Capitalization (2010 - 2026)

Immucell (ICCC) has reported Market Capitalization for 17 consecutive years, with $91.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 44.98% year-over-year to $91.3 million; the trailing twelve-month figure through Jun 2026 stood at $91.3 million (up 44.98% YoY), and the FY2025 full-year result was $55.6 million, up 20.31% from the prior year.
• Market Capitalization climbed to $91.3 million in Q2 2026 per ICCC's latest filing, from $55.6 million in the prior quarter.
• Across five years, Market Capitalization topped out at $91.3 million in Q2 2026 and bottomed at $32.1 million in Q3 2024.
• Historically, Market Capitalization has averaged $51.4 million across 5 years, with a median of $46.2 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization tumbled 46.5% in 2023, then soared 76.32% in 2025.
• Over 5 years, Market Capitalization stood at $47.3 million in 2022, then slipped by 16.51% to $39.5 million in 2023, then climbed by 17.21% to $46.2 million in 2024, then increased by 20.31% to $55.6 million in 2025, then surged by 64.07% to $91.3 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $91.3 million, $55.6 million, and $56.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.